These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 27358065)

  • 1. Epigenetic regulation in Parkinson's disease.
    Labbé C; Lorenzo-Betancor O; Ross OA
    Acta Neuropathol; 2016 Oct; 132(4):515-30. PubMed ID: 27358065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic mechanisms in Parkinson's disease.
    Feng Y; Jankovic J; Wu YC
    J Neurol Sci; 2015 Feb; 349(1-2):3-9. PubMed ID: 25553963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic-based therapies.
    Renani PG; Taheri F; Rostami D; Farahani N; Abdolkarimi H; Abdollahi E; Taghizadeh E; Gheibi Hayat SM
    J Cell Physiol; 2019 Nov; 234(11):19307-19319. PubMed ID: 30968426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in Parkinson's Disease.
    Pavlou MAS; Outeiro TF
    Adv Exp Med Biol; 2017; 978():363-390. PubMed ID: 28523556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation in Parkinson's disease.
    Wüllner U; Kaut O; deBoni L; Piston D; Schmitt I
    J Neurochem; 2016 Oct; 139 Suppl 1():108-120. PubMed ID: 27120258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview of Epigenetic Changes in the Parkinson's Disease Brain.
    Klokkaris A; Migdalska-Richards A
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting epigenetic modifications in Parkinson's disease therapy.
    Zhang D; Zhang J; Wang Y; Wang G; Tang P; Liu Y; Zhang Y; Ouyang L
    Med Res Rev; 2023 Sep; 43(5):1748-1777. PubMed ID: 37119043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities.
    Ammal Kaidery N; Tarannum S; Thomas B
    Neurotherapeutics; 2013 Oct; 10(4):698-708. PubMed ID: 24030213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain.
    Toker L; Tran GT; Sundaresan J; Tysnes OB; Alves G; Haugarvoll K; Nido GS; Dölle C; Tzoulis C
    Mol Neurodegener; 2021 May; 16(1):31. PubMed ID: 33947435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the Expression and Epigenetics of Genes Involved in Monogenic Forms of Parkinson's Disease Influence Sporadic Forms?
    Lanore A; Lesage S; Mariani LL; Menon PJ; Ravassard P; Cheval H; Corti O; Brice A; Corvol JC
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.
    Eryilmaz IE; Cecener G; Erer S; Egeli U; Tunca B; Zarifoglu M; Elibol B; Bora Tokcaer A; Saka E; Demirkiran M; Akbostanci C; Dogu O; Colakoglu B; Kenangil G; Kaleagasi H
    Neurol Res; 2017 Nov; 39(11):965-972. PubMed ID: 28830306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.
    Guhathakurta S; Bok E; Evangelista BA; Kim YS
    Prog Neurobiol; 2017 Jul; 154():21-36. PubMed ID: 28445713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the Complex Interplay between Alpha-Synuclein and Epigenetic Modification.
    Sugeno N; Hasegawa T
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Modulation in Parkinson's Disease and Potential Treatment Therapies.
    Rathore AS; Birla H; Singh SS; Zahra W; Dilnashin H; Singh R; Keshri PK; Singh SP
    Neurochem Res; 2021 Jul; 46(7):1618-1626. PubMed ID: 33900517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.
    Jowaed A; Schmitt I; Kaut O; Wüllner U
    J Neurosci; 2010 May; 30(18):6355-9. PubMed ID: 20445061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurodegeneration and epigenetics].
    Iwata A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):269-73. PubMed ID: 23373314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets.
    Kia DA; Zhang D; Guelfi S; Manzoni C; Hubbard L; Reynolds RH; Botía J; Ryten M; Ferrari R; Lewis PA; Williams N; Trabzuni D; Hardy J; Wood NW;
    JAMA Neurol; 2021 Apr; 78(4):464-472. PubMed ID: 33523105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common genetic variants associated with Parkinson's disease display widespread signature of epigenetic plasticity.
    Sharma A; Osato N; Liu H; Asthana S; Dakal TC; Ambrosini G; Bucher P; Schmitt I; Wüllner U
    Sci Rep; 2019 Dec; 9(1):18464. PubMed ID: 31804560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of epigenetics in Alzheimer's and Parkinson's disease.
    Kwok JB
    Epigenomics; 2010 Oct; 2(5):671-82. PubMed ID: 22122050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.